<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39164752</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1868-7083</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>20</Day></PubDate></JournalIssue><Title>Clinical epigenetics</Title><ISOAbbreviation>Clin Epigenetics</ISOAbbreviation></Journal><ArticleTitle>Epigenetic patterns, accelerated biological aging, and enhanced epigenetic drift detected 6 months following COVID-19 infection: insights from a genome-wide DNA methylation study.</ArticleTitle><Pagination><StartPage>112</StartPage><MedlinePgn>112</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">112</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13148-024-01724-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The epigenetic status of patients 6-month post-COVID-19 infection remains largely unexplored. The existence of long-COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), suggests potential long-term changes. Long-COVID includes symptoms like fatigue, neurological issues, and organ-related problems, regardless of initial infection severity. The mechanisms behind long-COVID are unclear, but virus-induced epigenetic changes could play a role.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Our study explores the lasting epigenetic impacts of SARS-CoV-2 infection. We analyzed genome-wide DNA methylation patterns in an Italian cohort of 96 patients 6 months after COVID-19 exposure, comparing them to 191 healthy controls. We identified 42 CpG sites with significant methylation differences (FDR&#x2009;&lt;&#x2009;0.05), primarily within CpG islands and gene promoters. Dysregulated genes highlighted potential links to glutamate/glutamine metabolism, which may be relevant to PASC symptoms. Key genes with potential significance to COVID-19 infection and long-term effects include GLUD1, ATP1A3, and ARRB2. Furthermore, Horvath's epigenetic clock showed a slight but significant age acceleration in post-COVID-19 patients. We also observed a substantial increase in stochastic epigenetic mutations (SEMs) in the post-COVID-19 group, implying potential epigenetic drift. SEM analysis identified 790 affected genes, indicating dysregulation in pathways related to insulin resistance, VEGF signaling, apoptosis, hypoxia response, T-cell activation, and endothelin signaling.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study provides valuable insights into the epigenetic consequences of COVID-19. Results suggest possible associations with accelerated aging, epigenetic drift, and the disruption of critical biological pathways linked to insulin resistance, immune response, and vascular health. Understanding these epigenetic changes could be crucial for elucidating the complex mechanisms behind long-COVID and developing targeted therapeutic interventions.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luciano</LastName><ForeName>Calzari</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bioinformatics and Statistical Genomics Unit, IRCCS Istituto Auxologico Italiano, Cusano Milanino, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernando</LastName><ForeName>Dragani Davide</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Bioinformatics and Statistical Genomics Unit, IRCCS Istituto Auxologico Italiano, Cusano Milanino, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucia</LastName><ForeName>Zanotti</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, S. Luca Hospital, IRCCS, Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elvira</LastName><ForeName>Inglese</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Clinical Chemistry Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Behavioral Sciences, University of Pavia, Via Bassi 21, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romano</LastName><ForeName>Danesi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinical Chemistry Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rebecca</LastName><ForeName>Cavagnola</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Brain and Behavioral Sciences, University of Pavia, Via Bassi 21, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alberto</LastName><ForeName>Brusati</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Brain and Behavioral Sciences, University of Pavia, Via Bassi 21, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francesco</LastName><ForeName>Ranucci</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Brain and Behavioral Sciences, University of Pavia, Via Bassi 21, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maria</LastName><ForeName>Di Blasio Anna</ForeName><Initials>DBA</Initials><AffiliationInfo><Affiliation>Molecular Biology Laboratory, IRCCS Istituto Auxologico Italiano, Cusano Milanino, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luca</LastName><ForeName>Persani</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrine and Metabolic Diseases, Lab of Endocrine and Metabolic Research, San Luca Hospital, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irene</LastName><ForeName>Campi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Endocrine and Metabolic Diseases, Lab of Endocrine and Metabolic Research, San Luca Hospital, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sara</LastName><ForeName>De Martino</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Consiglio Nazionale delle Ricerche (CNR) - IASI, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonella</LastName><ForeName>Farsetti</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Consiglio Nazionale delle Ricerche (CNR) - IASI, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veronica</LastName><ForeName>Barbi</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Laboratorio di Epigenetica, Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 4, 27100, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michela</LastName><ForeName>Gottardi Zamperla</ForeName><Initials>GZ</Initials><AffiliationInfo><Affiliation>Laboratorio di Epigenetica, Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 4, 27100, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicole</LastName><ForeName>Baldrighi Giulia</ForeName><Initials>BG</Initials><AffiliationInfo><Affiliation>Department of Brain and Behavioral Sciences, University of Pavia, Via Bassi 21, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlo</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratorio di Epigenetica, Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 4, 27100, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gianfranco</LastName><ForeName>Parati</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, S. Luca Hospital, IRCCS, Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davide</LastName><ForeName>Gentilini</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Bioinformatics and Statistical Genomics Unit, IRCCS Istituto Auxologico Italiano, Cusano Milanino, Milan, Italy. d.gentilini@auxologico.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Behavioral Sciences, University of Pavia, Via Bassi 21, Pavia, Italy. d.gentilini@auxologico.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RCR-2020-23670065</GrantID><Agency>Ricerca Corrente Reti 2020</Agency><Country/></Grant><Grant><GrantID>RCR-2020-23670065</GrantID><Agency>Ricerca Corrente Reti 2020</Agency><Country/></Grant><Grant><GrantID>RCR-2020-23670065</GrantID><Agency>Ricerca Corrente Reti 2020</Agency><Country/></Grant><Grant><GrantID>RCR-2020-23670065</GrantID><Agency>Ricerca Corrente Reti 2020</Agency><Country/></Grant><Grant><GrantID>RCR-2021-23671212</GrantID><Agency>Ricerca Corrente Reti 2021</Agency><Country/></Grant><Grant><GrantID>RCR-2021-23671212</GrantID><Agency>Ricerca Corrente Reti 2021</Agency><Country/></Grant><Grant><GrantID>RCR-2021-23671212</GrantID><Agency>Ricerca Corrente Reti 2021</Agency><Country/></Grant><Grant><GrantID>RCR-2021-23671212</GrantID><Agency>Ricerca Corrente Reti 2021</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Epigenetics</MedlineTA><NlmUniqueID>101516977</NlmUniqueID><ISSNLinking>1868-7075</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="Y">DNA Methylation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018899" MajorTopicYN="Y">CpG Islands</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">DNA methylation</Keyword><Keyword MajorTopicYN="N">EWAS</Keyword><Keyword MajorTopicYN="N">Epigenetic clock</Keyword><Keyword MajorTopicYN="N">Epigenetic drift</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Stochastic epigenetic mutation</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>21</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>21</Day><Hour>3</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>20</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39164752</ArticleId><ArticleId IdType="pmc">PMC11337605</ArticleId><ArticleId IdType="doi">10.1186/s13148-024-01724-9</ArticleId><ArticleId IdType="pii">10.1186/s13148-024-01724-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Balnis J, Madrid A, Hogan KJ, Drake LA, Chieng HC, Tiwari A, et al. Blood DNA methylation and COVID-19 outcomes. Clin Epigenetics. 2021;13(1):118. 10.1186/s13148-021-01102-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-021-01102-9</ArticleId><ArticleId IdType="pmc">PMC8148415</ArticleId><ArticleId IdType="pubmed">34034806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradic M, Taleb S, Thomas B, Chidiac O, Robay A, Hassan N, et al. DNA methylation predicts the outcome of COVID-19 patients with acute respiratory distress syndrome. J Transl Med. 2022;20(1):526. 10.1186/s12967-022-03737-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03737-5</ArticleId><ArticleId IdType="pmc">PMC9652914</ArticleId><ArticleId IdType="pubmed">36371196</ArticleId></ArticleIdList></Reference><Reference><Citation>Calzari L, Zanotti L, Inglese E, Scaglione F, Cavagnola R, Ranucci F, et al. Role of epigenetics in the clinical evolution of COVID-19 disease. Epigenome-wide association study identifies markers of severe outcome. Eur J Med Res. 2023;28(1):81. 10.1186/s40001-023-01032-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-023-01032-7</ArticleId><ArticleId IdType="pmc">PMC9936487</ArticleId><ArticleId IdType="pubmed">36800980</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro de Moura M, Davalos V, Planas-Serra L, Alvarez-Errico D, Arribas C, Ruiz M, et al. Epigenome-wide association study of COVID-19 severity with respiratory failure. EBioMedicine. 2021;66:103339. 10.1016/j.ebiom.2021.103339</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103339</ArticleId><ArticleId IdType="pmc">PMC8047083</ArticleId><ArticleId IdType="pubmed">33867313</ArticleId></ArticleIdList></Reference><Reference><Citation>Corley MJ, Pang APS, Dody K, Mudd PA, Patterson BK, Seethamraju H, et al. Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19. J Leukoc Biol. 2021;110(1):21&#x2013;6. 10.1002/JLB.5HI0720-466R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.5HI0720-466R</ArticleId><ArticleId IdType="pmc">PMC8013321</ArticleId><ArticleId IdType="pubmed">33464637</ArticleId></ArticleIdList></Reference><Reference><Citation>Konigsberg IR, Barnes B, Campbell M, Davidson E, Zhen Y, Pallisard O, et al. Host methylation predicts SARS-CoV-2 infection and clinical outcome. Commun Med (London). 2021;1(1):42.10.1038/s43856-021-00042-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-021-00042-y</ArticleId><ArticleId IdType="pmc">PMC8767772</ArticleId><ArticleId IdType="pubmed">35072167</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Zhang J, Xu J, Zhang F, Li P, He Y, et al. An epigenome-wide DNA methylation study of patients with COVID-19. Ann Hum Genet. 2021;85(6):221&#x2013;34. 10.1111/ahg.12440</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ahg.12440</ArticleId><ArticleId IdType="pmc">PMC8441705</ArticleId><ArticleId IdType="pubmed">34185889</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura H, Cohen JI. Chronic active Epstein&#x2013;Barr virus disease. Front Immunol. 2017;8:1867. 10.3389/fimmu.2017.01867</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01867</ArticleId><ArticleId IdType="pmc">PMC5770746</ArticleId><ArticleId IdType="pubmed">29375552</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristiansen MS, Stabursvik J, O&#x2019;Leary EC, Pedersen M, Asprusten TT, Leegaard T, et al. Clinical symptoms and markers of disease mechanisms in adolescent chronic fatigue following Epstein&#x2013;Barr virus infection: an exploratory cross-sectional study. Brain Behav Immun. 2019;80:551&#x2013;63. 10.1016/j.bbi.2019.04.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.04.040</ArticleId><ArticleId IdType="pubmed">31039432</ArticleId></ArticleIdList></Reference><Reference><Citation>Britt W. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr Top Microbiol Immunol. 2008;325:417&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">18637519</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodrum F, Caviness K, Zagallo P. Human cytomegalovirus persistence. Cell Microbiol. 2012;14(5):644&#x2013;55. 10.1111/j.1462-5822.2012.01774.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2012.01774.x</ArticleId><ArticleId IdType="pmc">PMC3330195</ArticleId><ArticleId IdType="pubmed">22329758</ArticleId></ArticleIdList></Reference><Reference><Citation>Straus SE. Studies of herpesvirus infection in chronic fatigue syndrome. Ciba Found Symp. 1993;173:132&#x2013;9; discussion 9&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">8387907</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12: 698169. 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L, Tosto-Mancuso J, Wood J, Cortes M, Kontorovich A, McCarthy D, et al. Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am J Phys Med Rehabil. 2022;101(1):48&#x2013;52. 10.1097/PHM.0000000000001910</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110(21):3484&#x2013;96. 10.1016/j.neuron.2022.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, Luscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157&#x2013;72. 10.1093/eurheartj/ehac031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Sanchis-Gomar F, Henry BM. COVID-19 and its long-term sequelae: what do we know in 2023? Pol Arch Intern Med. 2023;133(4):16402.</Citation><ArticleIdList><ArticleId IdType="pubmed">36626183</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593&#x2013;607. 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Palacios-Cena D, Gomez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. 2021;92:55&#x2013;70. 10.1016/j.ejim.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11(2):269. 10.3390/pathogens11020269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine. 2023;55: 101762. 10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, de Oliveira MHS, Peligro PJ, Velasco JV, Macaranas I, Ver AT, et al. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: a systematic review and meta-analysis. J Clin Med. 2022;11(24):7314. 10.3390/jcm11247314</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 2021;218(3):e20202135. 10.1084/jem.20202135</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibholm LK, Nielsen SSF, Pahus MH, Frattari GS, Olesen R, Andersen R, et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine. 2021;64: 103230. 10.1016/j.ebiom.2021.103230</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103230</ArticleId><ArticleId IdType="pmc">PMC7847186</ArticleId><ArticleId IdType="pubmed">33530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;46. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013&#x2013;22. 10.1002/jmv.26368</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond MS, Kanneganti TD. Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol. 2022;23(2):165&#x2013;76. 10.1038/s41590-021-01091-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01091-0</ArticleId><ArticleId IdType="pmc">PMC8935980</ArticleId><ArticleId IdType="pubmed">35105981</ArticleId></ArticleIdList></Reference><Reference><Citation>Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, et al. Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021;184(1):149-68 e17. 10.1016/j.cell.2020.11.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.025</ArticleId><ArticleId IdType="pmc">PMC7674074</ArticleId><ArticleId IdType="pubmed">33278357</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga L, Ali H, Secco I, Chiavacci E, Neves G, Goldhill D, et al. Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia. Nature. 2021;594(7861):88&#x2013;93. 10.1038/s41586-021-03491-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03491-6</ArticleId><ArticleId IdType="pmc">PMC7611055</ArticleId><ArticleId IdType="pubmed">33827113</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Li Q, Wang Y, Shi Y. Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes. Cell Death Differ. 2021;28(6):2019&#x2013;21. 10.1038/s41418-021-00795-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00795-y</ArticleId><ArticleId IdType="pmc">PMC8114657</ArticleId><ArticleId IdType="pubmed">33981020</ArticleId></ArticleIdList></Reference><Reference><Citation>Damoiseaux J, Dotan A, Fritzler MJ, Bogdanos DP, Meroni PL, Roggenbuck D, et al. Autoantibodies and SARS-CoV2 infection: the spectrum from association to clinical implication: report of the 15th Dresden Symposium on Autoantibodies. Autoimmun Rev. 2022;21(3): 103012. 10.1016/j.autrev.2021.103012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.103012</ArticleId><ArticleId IdType="pmc">PMC8656211</ArticleId><ArticleId IdType="pubmed">34896650</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A, Vlok M, Turner S, Venter C, Laubscher GJ, Kell DB, et al. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc Diabetol. 2022;21(1):190. 10.1186/s12933-022-01623-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01623-4</ArticleId><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, Naidoo CA, Usher TJ, Kruger A, Venter C, Laubscher GJ, et al. Increased levels of inflammatory and endothelial biomarkers in blood of long COVID patients point to thrombotic endothelialitis. Semin Thromb Hemost. 2023;50:288&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">37207671</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank MG, Nguyen KH, Ball JB, Hopkins S, Kelley T, Baratta MV, et al. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: evidence of PAMP-like properties. Brain Behav Immun. 2022;100:267&#x2013;77. 10.1016/j.bbi.2021.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.007</ArticleId><ArticleId IdType="pmc">PMC8667429</ArticleId><ArticleId IdType="pubmed">34915155</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Fan J, Huang J, Guo E, Fu Y, Liu S, et al. Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection. Nat Commun. 2021;12(1):3501. 10.1038/s41467-021-23621-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23621-y</ArticleId><ArticleId IdType="pmc">PMC8190301</ArticleId><ArticleId IdType="pubmed">34108465</ArticleId></ArticleIdList></Reference><Reference><Citation>Balnis J, Madrid A, Hogan KJ, Drake LA, Adhikari A, Vancavage R, et al. Persistent blood DNA methylation changes one year after SARS-CoV-2 infection. Clin Epigenetics. 2022;14(1):94. 10.1186/s13148-022-01313-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-022-01313-8</ArticleId><ArticleId IdType="pmc">PMC9308917</ArticleId><ArticleId IdType="pubmed">35871090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Riskedal E, Kalleberg KT, Istre M, Lind A, Lund-Johansen F, et al. EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection. Sci Rep. 2022;12(1):11478. 10.1038/s41598-022-15467-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15467-1</ArticleId><ArticleId IdType="pmc">PMC9261254</ArticleId><ArticleId IdType="pubmed">35798818</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikesjo F, Sayyab S, Karlsson L, Apostolou E, Rosen A, Hedman K, et al. Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells. Clin Epigenetics. 2022;14(1):172. 10.1186/s13148-022-01398-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-022-01398-1</ArticleId><ArticleId IdType="pmc">PMC9748378</ArticleId><ArticleId IdType="pubmed">36517875</ArticleId></ArticleIdList></Reference><Reference><Citation>Teschendorff AE, Breeze CE, Zheng SC, Beck S. A comparison of reference-based algorithms for correcting cell-type heterogeneity in Epigenome-Wide Association Studies. BMC Bioinf. 2017;18(1):105.10.1186/s12859-017-1511-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-017-1511-5</ArticleId><ArticleId IdType="pmc">PMC5307731</ArticleId><ArticleId IdType="pubmed">28193155</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7): e47. 10.1093/nar/gkv007</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115. 10.1186/gb-2013-14-10-r115</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2013-14-10-r115</ArticleId><ArticleId IdType="pmc">PMC4015143</ArticleId><ArticleId IdType="pubmed">24138928</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013;49(2):359&#x2013;67. 10.1016/j.molcel.2012.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2012.10.016</ArticleId><ArticleId IdType="pmc">PMC3780611</ArticleId><ArticleId IdType="pubmed">23177740</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath S, Oshima J, Martin GM, Lu AT, Quach A, Cohen H, et al. Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies. Aging (Albany NY). 2018;10(7):1758&#x2013;75. 10.18632/aging.101508</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101508</ArticleId><ArticleId IdType="pmc">PMC6075434</ArticleId><ArticleId IdType="pubmed">30048243</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10(4):573&#x2013;91. 10.18632/aging.101414</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101414</ArticleId><ArticleId IdType="pmc">PMC5940111</ArticleId><ArticleId IdType="pubmed">29676998</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu AT, Seeboth A, Tsai PC, Sun D, Quach A, Reiner AP, et al. DNA methylation-based estimator of telomere length. Aging (Albany NY). 2019;11(16):5895&#x2013;923. 10.18632/aging.102173</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102173</ArticleId><ArticleId IdType="pmc">PMC6738410</ArticleId><ArticleId IdType="pubmed">31422385</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentilini D, Garagnani P, Pisoni S, Bacalini MG, Calzari L, Mari D, et al. Stochastic epigenetic mutations (DNA methylation) increase exponentially in human aging and correlate with X chromosome inactivation skewing in females. Aging (Albany NY). 2015;7(8):568&#x2013;78. 10.18632/aging.100792</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.100792</ArticleId><ArticleId IdType="pmc">PMC4586102</ArticleId><ArticleId IdType="pubmed">26342808</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentilini D, Scala S, Gaudenzi G, Garagnani P, Capri M, Cescon M, et al. Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach. Oncotarget. 2017;8(26):41890&#x2013;902. 10.18632/oncotarget.17462</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.17462</ArticleId><ArticleId IdType="pmc">PMC5522036</ArticleId><ArticleId IdType="pubmed">28514750</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentilini D, Somigliana E, Pagliardini L, Rabellotti E, Garagnani P, Bernardinelli L, et al. Multifactorial analysis of the stochastic epigenetic variability in cord blood confirmed an impact of common behavioral and environmental factors but not of in vitro conception. Clin Epigenetics. 2018;10:77. 10.1186/s13148-018-0510-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-018-0510-3</ArticleId><ArticleId IdType="pmc">PMC5994106</ArticleId><ArticleId IdType="pubmed">29930742</ArticleId></ArticleIdList></Reference><Reference><Citation>Guida V, Calzari L, Fadda MT, Piceci-Sparascio F, Digilio MC, Bernardini L, et al. Genome-wide DNA methylation analysis of a cohort of 41 patients affected by Oculo-auriculo-vertebral spectrum (OAVS). Int J Mol Sci. 2021;22(3):1190. 10.3390/ijms22031190</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22031190</ArticleId><ArticleId IdType="pmc">PMC7866060</ArticleId><ArticleId IdType="pubmed">33530447</ArticleId></ArticleIdList></Reference><Reference><Citation>Spada E, Calzari L, Corsaro L, Fazia T, Mencarelli M, Di Blasio AM, et al. Epigenome wide association and stochastic epigenetic mutation analysis on cord blood of preterm birth. Int J Mol Sci. 2020;21(14):5044. 10.3390/ijms21145044</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21145044</ArticleId><ArticleId IdType="pmc">PMC7403978</ArticleId><ArticleId IdType="pubmed">32708910</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan X, Hu Y, Li B, Abecasis GR, Liu DJ. RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data. Bioinformatics. 2016;32(9):1423&#x2013;6. 10.1093/bioinformatics/btw079</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw079</ArticleId><ArticleId IdType="pmc">PMC4848408</ArticleId><ArticleId IdType="pubmed">27153000</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XK, Tu B, Zhang XA, Xu W, Chen JH, Zhao GY, et al. Dysregulation of glutamine/glutamate metabolism in COVID-19 patients: a metabolism study in African population and mini meta-analysis. J Med Virol. 2023;95(1): e28150. 10.1002/jmv.28150</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28150</ArticleId><ArticleId IdType="pmc">PMC9538869</ArticleId><ArticleId IdType="pubmed">36112136</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M, Canoll PD, Klein RS. How COVID-19 Affects the Brain. JAMA Psychiat. 2021;78(6):682&#x2013;3.10.1001/jamapsychiatry.2021.0500</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.0500</ArticleId><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Yesilkaya UH, Sen M, Balcioglu YH. COVID-19-related cognitive dysfunction may be associated with transient disruption in the DLPFC glutamatergic pathway. J Clin Neurosci. 2021;87:153&#x2013;5. 10.1016/j.jocn.2021.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2021.03.007</ArticleId><ArticleId IdType="pmc">PMC7955917</ArticleId><ArticleId IdType="pubmed">33863524</ArticleId></ArticleIdList></Reference><Reference><Citation>Vezyroglou A, Akilapa R, Barwick K, Koene S, Brownstein CA, Holder-Espinasse M, et al. The phenotypic continuum of ATP1A3-related disorders. Neurology. 2022;99(14):e1511&#x2013;26. 10.1212/WNL.0000000000200927</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000200927</ArticleId><ArticleId IdType="pmc">PMC9576304</ArticleId><ArticleId IdType="pubmed">36192182</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestrini S, Mikati MA, Alvarez-Garcia-Roves R, Carboni M, Hunanyan AS, Kherallah B, et al. Cardiac phenotype in ATP1A3-related syndromes: a multicenter cohort study. Neurology. 2020;95(21):e2866&#x2013;79. 10.1212/WNL.0000000000010794</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010794</ArticleId><ArticleId IdType="pmc">PMC7734736</ArticleId><ArticleId IdType="pubmed">32913013</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuang SY, Li Y, Yang SL, Han X. Child neurology: aicardi-goutieres syndrome presenting as recurrent ischemic stroke. Neurology. 2022;99(9):393&#x2013;8. 10.1212/WNL.0000000000200952</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000200952</ArticleId><ArticleId IdType="pmc">PMC9502735</ArticleId><ArticleId IdType="pubmed">35803721</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice G, Patrick T, Parmar R, Taylor CF, Aeby A, Aicardi J, et al. Clinical and molecular phenotype of Aicardi&#x2013;Goutieres syndrome. Am J Hum Genet. 2007;81(4):713&#x2013;25. 10.1086/521373</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/521373</ArticleId><ArticleId IdType="pmc">PMC2227922</ArticleId><ArticleId IdType="pubmed">17846997</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Xiong F, Wu G, Wang D, Liu W, Chen J, et al. SMAD proteins in TGF-beta signalling pathway in cancer: regulatory mechanisms and clinical applications. Diagnostics (Basel). 2023;13(17):2769. 10.3390/diagnostics13172769</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13172769</ArticleId><ArticleId IdType="pmc">PMC10487229</ArticleId><ArticleId IdType="pubmed">37685308</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai LYS, Gracie NP, Gowripalan A, Howell LM, Newsome TP. SMAD proteins: mediators of diverse outcomes during infection. Eur J Cell Biol. 2022;101(2): 151204. 10.1016/j.ejcb.2022.151204</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcb.2022.151204</ArticleId><ArticleId IdType="pubmed">35131661</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamilov R, Aneskievich BJ. TNIP1 in autoimmune diseases: regulation of toll-like receptor signaling. J Immunol Res. 2018;2018:3491269. 10.1155/2018/3491269</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/3491269</ArticleId><ArticleId IdType="pmc">PMC6192141</ArticleId><ArticleId IdType="pubmed">30402506</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam T, Rahman MR, Aydin B, Beklen H, Arga KY, Shahjaman M. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19. Eur J Pharmacol. 2020;887: 173594. 10.1016/j.ejphar.2020.173594</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173594</ArticleId><ArticleId IdType="pmc">PMC7505772</ArticleId><ArticleId IdType="pubmed">32971089</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray NR, Kalari KR, Fields AP. Protein kinase Ciota expression and oncogenic signaling mechanisms in cancer. J Cell Physiol. 2011;226(4):879&#x2013;87. 10.1002/jcp.22463</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.22463</ArticleId><ArticleId IdType="pmc">PMC3075823</ArticleId><ArticleId IdType="pubmed">20945390</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosse C, Linch M, Kermorgant S, Cameron AJ, Boeckeler K, Parker PJ. PKC and the control of localized signal dynamics. Nat Rev Mol Cell Biol. 2010;11(2):103&#x2013;12. 10.1038/nrm2847</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2847</ArticleId><ArticleId IdType="pubmed">20094051</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y, Jiang Q, Li S, Zhu H, Xu R, Song N, et al. Opposing functions of beta-arrestin 1 and 2 in Parkinson&#x2019;s disease via microglia inflammation and Nprl3. Cell Death Differ. 2021;28(6):1822&#x2013;36. 10.1038/s41418-020-00704-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-00704-9</ArticleId><ArticleId IdType="pmc">PMC8184754</ArticleId><ArticleId IdType="pubmed">33686256</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, Yu JT, Wang YL, Wang HF, Zhang W, Hu N, et al. The genetic variation of ARRB2 is associated with late-onset Alzheimer&#x2019;s disease in Han Chinese. Curr Alzheimer Res. 2014;11(4):408&#x2013;12. 10.2174/1567205011666140317095014</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205011666140317095014</ArticleId><ArticleId IdType="pubmed">24635845</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu NM, Nakagawa P, Grobe CC, Reho JJ, Brozoski DT, Lu KT, et al. ARRB2 (beta-Arrestin-2) deficiency alters fluid homeostasis and blood pressure regulation. Hypertension. 2022;79(11):2480&#x2013;92. 10.1161/HYPERTENSIONAHA.122.19863</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.122.19863</ArticleId><ArticleId IdType="pmc">PMC9669141</ArticleId><ArticleId IdType="pubmed">36215165</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren H, Liu Y, Tan Z, Luo G, Zhang M, Li S, et al. A common variant of ARRB2 promoter region associated with the prognosis of heart failure. Hum Hered. 2023;88(1):68&#x2013;78. 10.1159/000530827</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000530827</ArticleId><ArticleId IdType="pubmed">37100034</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, Song H, Xu W, Zhang Y, Liu Y, Qi W. The comprehensive analysis of hub gene ARRB2 in prostate cancer. Dis Markers. 2022;2022:8518378. 10.1155/2022/8518378</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/8518378</ArticleId><ArticleId IdType="pmc">PMC9588343</ArticleId><ArticleId IdType="pubmed">36284990</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Li M, Li L, Qian G, Wang Y, Chen Z, et al. beta-arrestin 2 as an activator of cGAS-STING signaling and target of viral immune evasion. Nat Commun. 2020;11(1):6000. 10.1038/s41467-020-19849-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19849-9</ArticleId><ArticleId IdType="pmc">PMC7691508</ArticleId><ArticleId IdType="pubmed">33243993</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Gandy S. The Golgi apparatus: Site for convergence of COVID-19 brain fog and Alzheimer&#x2019;s disease? Mol Neurodegener. 2022;17(1):67. 10.1186/s13024-022-00568-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00568-2</ArticleId><ArticleId IdType="pmc">PMC9587685</ArticleId><ArticleId IdType="pubmed">36271398</ArticleId></ArticleIdList></Reference><Reference><Citation>Thayer DA, Jan YN, Jan LY. Increased neuronal activity fragments the Golgi complex. Proc Natl Acad Sci U S A. 2013;110(4):1482&#x2013;7. 10.1073/pnas.1220978110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1220978110</ArticleId><ArticleId IdType="pmc">PMC3557034</ArticleId><ArticleId IdType="pubmed">23297202</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzen J, Nuchtern S, Tharmapalan V, Vieri M, Nikolic M, Han Y, et al. Epigenetic clocks are not accelerated in COVID-19 patients. Int J Mol Sci. 2021;22(17):9306. 10.3390/ijms22179306</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22179306</ArticleId><ArticleId IdType="pmc">PMC8431654</ArticleId><ArticleId IdType="pubmed">34502212</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X, Li W, Wang T, Ran D, Davalos V, Planas-Serra L, et al. Accelerated biological aging in COVID-19 patients. Nat Commun. 2022;13(1):2135. 10.1038/s41467-022-29801-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29801-8</ArticleId><ArticleId IdType="pmc">PMC9018863</ArticleId><ArticleId IdType="pubmed">35440567</ArticleId></ArticleIdList></Reference><Reference><Citation>Bejaoui Y, Humaira Amanullah F, Saad M, Taleb S, Bradic M, Megarbane A, et al. Epigenetic age acceleration in surviving versus deceased COVID-19 patients with acute respiratory distress syndrome following hospitalization. Clin Epigenetics. 2023;15(1):186. 10.1186/s13148-023-01597-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-023-01597-4</ArticleId><ArticleId IdType="pmc">PMC10685564</ArticleId><ArticleId IdType="pubmed">38017502</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Vazquez R, Guio-Carrion A, Zapatero-Gaviria A, Martinez P, Blasco MA. Shorter telomere lengths in patients with severe COVID-19 disease. Aging (Albany NY). 2021;13(1):1&#x2013;15. 10.18632/aging.202463</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.202463</ArticleId><ArticleId IdType="pmc">PMC7835063</ArticleId><ArticleId IdType="pubmed">33428591</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongelli A, Barbi V, Gottardi Zamperla M, Atlante S, Forleo L, Nesta M, et al. Evidence for biological age acceleration and telomere shortening in COVID-19 survivors. Int J Mol Sci. 2021;22(11):6151. 10.3390/ijms22116151</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22116151</ArticleId><ArticleId IdType="pmc">PMC8201243</ArticleId><ArticleId IdType="pubmed">34200325</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Tollefsbol TO. Age-related epigenetic drift and phenotypic plasticity loss: implications in prevention of age-related human diseases. Epigenomics. 2016;8(12):1637&#x2013;51. 10.2217/epi-2016-0078</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/epi-2016-0078</ArticleId><ArticleId IdType="pmc">PMC5618938</ArticleId><ArticleId IdType="pubmed">27882781</ArticleId></ArticleIdList></Reference><Reference><Citation>Brusati A, Peverelli S, Calzari L, Tiloca C, Casiraghi V, Sorce MN, et al. Exploring epigenetic drift and rare epivariations in amyotrophic lateral sclerosis by epigenome-wide association study. Front Aging Neurosci. 2023;15:1272135. 10.3389/fnagi.2023.1272135</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2023.1272135</ArticleId><ArticleId IdType="pmc">PMC10711632</ArticleId><ArticleId IdType="pubmed">38090719</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen GK, Yan Q, Paul KC, Kusters CDJ, Folle AD, Furlong M, et al. Stochastic epigenetic mutations influence Parkinson&#x2019;s disease risk, progression, and mortality. J Parkinsons Dis. 2022;12(2):545&#x2013;56. 10.3233/JPD-212834</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-212834</ArticleId><ArticleId IdType="pmc">PMC9076404</ArticleId><ArticleId IdType="pubmed">34842194</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez MV, Kim JH, Budde JP, Black K, Medvedeva A, Saef B, et al. Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer disease. PLoS Genet. 2017;13(11): e1007045. 10.1371/journal.pgen.1007045</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007045</ArticleId><ArticleId IdType="pmc">PMC5683650</ArticleId><ArticleId IdType="pubmed">29091718</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojinovic D, Brison N, Ahmad S, Noens I, Pappa I, Karssen LC, et al. Variants in TTC25 affect autistic trait in patients with autism spectrum disorder and general population. Eur J Human Genet EJHG. 2017;25(8):982&#x2013;7. 10.1038/ejhg.2017.82</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2017.82</ArticleId><ArticleId IdType="pmc">PMC5567150</ArticleId><ArticleId IdType="pubmed">28513607</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Ma J, Li M, Zhu W, Zhou W, Shen L, et al. Different responses to risperidone treatment in Schizophrenia: a multicenter genome-wide association and whole exome sequencing joint study. Transl Psychiatry. 2022;12(1):173. 10.1038/s41398-022-01942-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-022-01942-w</ArticleId><ArticleId IdType="pmc">PMC9050705</ArticleId><ArticleId IdType="pubmed">35484098</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahani M, Dokaneheifard S, Mansouri K. Hypoxia: a key feature of COVID-19 launching activation of HIF-1 and cytokine storm. J Inflamm (Lond). 2020;17:33. 10.1186/s12950-020-00263-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12950-020-00263-3</ArticleId><ArticleId IdType="pmc">PMC7594974</ArticleId><ArticleId IdType="pubmed">33139969</ArticleId></ArticleIdList></Reference><Reference><Citation>Josuttis D, Schwedler C, Heymann G, Gumbel D, Schmittner MD, Kruse M, et al. Vascular endothelial growth factor as potential biomarker for COVID-19 severity. J Intensive Care Med. 2023;38(12):1165&#x2013;73. 10.1177/08850666231186787</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08850666231186787</ArticleId><ArticleId IdType="pmc">PMC10345830</ArticleId><ArticleId IdType="pubmed">37448220</ArticleId></ArticleIdList></Reference><Reference><Citation>Melincovici CS, Bosca AB, Susman S, Marginean M, Mihu C, Istrate M, et al. Vascular endothelial growth factor (VEGF): key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">30173249</ArticleId></ArticleIdList></Reference><Reference><Citation>Pine AB, Meizlish ML, Goshua G, Chang CH, Zhang H, Bishai J, et al. Circulating markers of angiogenesis and endotheliopathy in COVID-19. Pulm Circ. 2020;10(4):2045894020966547. 10.1177/2045894020966547</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2045894020966547</ArticleId><ArticleId IdType="pmc">PMC7691906</ArticleId><ArticleId IdType="pubmed">33282193</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadja DM, Philippe A, Bory O, Gendron N, Beauvais A, Gruest M, et al. Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality. J Thromb Haemost. 2021;19(7):1823&#x2013;30. 10.1111/jth.15339</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15339</ArticleId><ArticleId IdType="pmc">PMC8250221</ArticleId><ArticleId IdType="pubmed">33830623</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovas A, Osiaevi I, Buscher K, Sackarnd J, Tepasse PR, Fobker M, et al. Microvascular dysfunction in COVID-19: the MYSTIC study. Angiogenesis. 2021;24(1):145&#x2013;57. 10.1007/s10456-020-09753-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-020-09753-7</ArticleId><ArticleId IdType="pmc">PMC7556767</ArticleId><ArticleId IdType="pubmed">33058027</ArticleId></ArticleIdList></Reference><Reference><Citation>He X, Liu C, Peng J, Li Z, Li F, Wang J, et al. COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors. Signal Transduct Target Ther. 2021;6(1):427. 10.1038/s41392-021-00822-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00822-x</ArticleId><ArticleId IdType="pmc">PMC8674414</ArticleId><ArticleId IdType="pubmed">34916489</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader SM, Cooney JP, Pellegrini M, Doerflinger M. Programmed cell death: The pathways to severe COVID-19? Biochem J. 2022;479(5):609&#x2013;28. 10.1042/BCJ20210602</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20210602</ArticleId><ArticleId IdType="pmc">PMC9022977</ArticleId><ArticleId IdType="pubmed">35244141</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;6. 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Taeschler P, Adamo S, Deng Y, Cervia C, Zurbuchen Y, Chevrier S, et al. T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19. Allergy. 2022;77(8):2468&#x2013;81. 10.1111/all.15372</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15372</ArticleId><ArticleId IdType="pmc">PMC9347640</ArticleId><ArticleId IdType="pubmed">35567391</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris TJ, Butcher LM, Feber A, Teschendorff AE, Chakravarthy AR, Wojdacz TK, et al. ChAMP: 450k chip analysis methylation pipeline. Bioinformatics. 2014;30(3):428&#x2013;30. 10.1093/bioinformatics/btt684</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt684</ArticleId><ArticleId IdType="pmc">PMC3904520</ArticleId><ArticleId IdType="pubmed">24336642</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 2017;45(4): e22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5389466</ArticleId><ArticleId IdType="pubmed">27924034</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Huang J, Liu Y, Ma L, Potash JB, Han S. COMBAT: a combined association test for genes using summary statistics. Genetics. 2017;207(3):883&#x2013;91. 10.1534/genetics.117.300257</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.117.300257</ArticleId><ArticleId IdType="pmc">PMC5676236</ArticleId><ArticleId IdType="pubmed">28878002</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller F, Scherer M, Assenov Y, Lutsik P, Walter J, Lengauer T, et al. RnBeads 2.0: comprehensive analysis of DNA methylation data. Genome Biol. 2019;20(1):55. 10.1186/s13059-019-1664-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-019-1664-9</ArticleId><ArticleId IdType="pmc">PMC6419383</ArticleId><ArticleId IdType="pubmed">30871603</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X, Kuan PF. methylGSA: a Bioconductor package and Shiny app for DNA methylation data length bias adjustment in gene set testing. Bioinformatics. 2019;35(11):1958&#x2013;9. 10.1093/bioinformatics/bty892</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty892</ArticleId><ArticleId IdType="pubmed">30346483</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang X, Wang K. wANNOVAR: annotating genetic variants for personal genomes via the web. J Med Genet. 2012;49(7):433&#x2013;6. 10.1136/jmedgenet-2012-100918</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2012-100918</ArticleId><ArticleId IdType="pmc">PMC3556337</ArticleId><ArticleId IdType="pubmed">22717648</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Wang J, Jaehnig EJ, Shi Z, Zhang B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47(W1):W199&#x2013;205. 10.1093/nar/gkz401</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz401</ArticleId><ArticleId IdType="pmc">PMC6602449</ArticleId><ArticleId IdType="pubmed">31114916</ArticleId></ArticleIdList></Reference><Reference><Citation>Stelzer G, Plaschkes I, Oz-Levi D, Alkelai A, Olender T, Zimmerman S, et al. VarElect: the phenotype-based variation prioritizer of the GeneCards Suite. BMC Genom. 2016;17(Suppl 2):444.10.1186/s12864-016-2722-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-016-2722-2</ArticleId><ArticleId IdType="pmc">PMC4928145</ArticleId><ArticleId IdType="pubmed">27357693</ArticleId></ArticleIdList></Reference><Reference><Citation>Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26(17):2190&#x2013;1. 10.1093/bioinformatics/btq340</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq340</ArticleId><ArticleId IdType="pmc">PMC2922887</ArticleId><ArticleId IdType="pubmed">20616382</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>